Healio

Endologix acquires PQ Bypass, developer of percutaneous femoral-popliteal bypass for PAD

Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
Business Wire

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass, an innovative medical device company pioneering advancements in the treatment of complex peripheral artery disease (PAD), announces enrollment of the ...
BioWorld

DETOUR2 shows Endologix superficial femoral artery bypass on track

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...
Business Wire

PQ Bypass Receives FDA “Breakthrough Device Designation” for the World’s First Fully Percutaneous Femoral-Popliteal Bypass Device

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...